US Election begins to roll on, the Biden administration is reminding voters of past success while challenging healthcare ...

Heartbeam AI plus vectorcardiography (VCG) outperformed an expert panel of three cardiologists by 40% in detecting atrial ...

Patient-friendlier progesterone administration for luteal phase support is another unmet need in the female infertility ...

The trial enrolled MDS patients who have failed treatment with hypomethylating agents. Credit: PeopleImages.com – Yuri A / Shutterstock.com. Faron Pharmaceuticals has announced initial positive data ...

On Clinical Trials Day, we take a look at how sponsors are exploring alternative designs to study cell and gene therapies.

Kelly Franchetti discusses the evolving role of patient advocates and the key relationships needed to advance drug ...

Vicore Pharma has announced positive results from patients on the Phase IIa trial of buloxibutid in IPF. Image credit: Shutterstock / Lana Leon. Vicore Pharma is looking to move ahead with the Phase ...

Bayer’s elinzanetant is a dual neurokinin-1 and 3 (NK-1 and 3) receptor agonist. Image Credit: Poetra.RH / Shutterstock. Bayer’s non-hormonal therapy elinzanetant met primary and secondary endpoints ...

The Phase III QWINT-2 and QWINT-4 trials analysed Eli Lilly’s insulin efsitora alfa (efsitora) for adults with type 2 diabetes. Credit: Tada Images/ Shutterstock.com. Eli Lilly has reported positive ...

Trial subjects aged 12 years and above were given a 300mg intramuscular dose of sipavibart or a comparator. Credit: BaLL LunLa / Shutterstock.com. AstraZeneca has announced that the Phase III ...

In the United States, the number of adults aged 65 and over is expected to grow sharply over the next three decades, rising 47% from 58 million in 2022 to 82 million by 2050. It is vitally important ...

The FDA report highlights the number of patients, categorising by gender, race and ethnicity, who are participating in trials in the US. Image credit: Shutterstock / melitas. The US Food and Drug ...